American Well Corporation
US ˙ NYSE

Introduction

This page provides a comprehensive analysis of the known insider trading history of Deval L Patrick. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Deval L Patrick has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:TWLO / Twilio Inc. Director 16,264
US:TOST / Toast, Inc. Director 13,260
US:CERE / Cerevel Therapeutics Holdings, Inc. Director 0
US:GRNA / GreenLight Biosciences Inc 0
US:AMWL / American Well Corporation Director 169,892
US:GBT / Global Blood Therapeutics Inc. Director 0
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Deval L Patrick. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases AMWL / American Well Corporation - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in AMWL / American Well Corporation. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2020-09-17 AMWL PATRICK DEVAL L 3,000 18.0000 150 360.0000 54,000 132 42.8 -47,580 -88.11
2020-09-17 AMWL PATRICK DEVAL L 8,000 18.0000 400 360.0000 144,000

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

AMWL / American Well Corporation Insider Trades
Insider Sales AMWL / American Well Corporation - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in AMWL / American Well Corporation. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

AMWL / American Well Corporation Insider Trades
Insider Purchases TOST / Toast, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in AMWL / American Well Corporation. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2021-09-24 TOST PATRICK DEVAL L 1,667 40.0000 1,667 40.0000 66,680 39 65.22 42,042 63.05

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

TOST / Toast, Inc. Insider Trades
Insider Sales TOST / Toast, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in AMWL / American Well Corporation. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2025-03-13 TOST PATRICK DEVAL L 34,222 33.0060 34,222 33.0060 1,129,531 26 30.0300 -101,844 -9.02

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

TOST / Toast, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Deval L Patrick as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-06-11 2025-06-09 4 TWLO TWILIO INC
Class A Common Stock
A - Award 691 16,264 4.44
2025-03-18 2025-03-15 4 TWLO TWILIO INC
Class A Common Stock
A - Award 618 15,573 4.13
2025-03-14 2025-03-13 4 TOST Toast, Inc.
Class A Common Stock
S - Sale -34,222 13,260 -72.07 33.01 -1,129,531 437,660
2024-12-17 2024-12-15 4 TWLO TWILIO INC
Class A Common Stock
A - Award 732 14,955 5.15
2024-09-17 2024-09-15 4 TWLO TWILIO INC
Class A Common Stock
A - Award 1,240 14,223 9.55
2024-08-05 2024-08-01 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
D - Sale to Issuer -10,461 0 -100.00
2024-08-05 2024-08-01 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
D - Sale to Issuer -3,282 10,461 -23.88
2024-06-10 2024-06-06 4 TOST Toast, Inc.
Class A Common Stock
M - Exercise 11,593 47,482 32.30
2024-06-07 2024-06-05 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
A - Award 10,461 13,743 318.74
2024-06-07 2024-06-05 4 TWLO TWILIO INC
Class A Common Stock
A - Award 1,234 12,983 10.50
2024-03-19 2024-03-15 4 TWLO TWILIO INC
Class A Common Stock
A - Award 1,195 11,749 11.32
2024-02-26 2024-02-22 4 TOST Toast, Inc.
Class A Common Stock
M - Exercise 7,645 35,889 27.07
2023-12-19 2023-12-15 4 TWLO TWILIO INC
Class A Common Stock
A - Award 1,153 10,554 12.26
2023-11-03 2023-11-01 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -30,130 3,282 -90.18 25.00 -753,250 82,050
2023-11-03 2023-11-01 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 30,130 33,412 918.04 12.62 380,241 421,659
2023-09-19 2023-09-15 4 TWLO TWILIO INC
Class A Common Stock
A - Award 1,192 9,401 14.52
2023-07-26 2023-07-24 4 GRNA GreenLight Biosciences Holdings, PBC
Common Stock, par value $0.0001 per share
J - Other -172,500 0 -100.00
2023-06-26 2023-06-22 4 AMWL American Well Corp
Class A Common Stock
A - Award 91,743 169,892 117.39
2023-06-14 2023-06-12 4 TWLO TWILIO INC
Class A Common Stock
A - Award 1,310 8,209 18.99
2023-06-09 2023-06-07 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
A - Award 3,282 3,282
2023-06-05 2023-06-02 4 TOST Toast, Inc.
Class A Common Stock
M - Exercise 11,292 28,244 66.61
2023-03-17 2023-03-15 4 TWLO TWILIO INC
Class A Common Stock
A - Award 1,101 6,899 18.99
2023-02-24 2023-02-22 4 TOST Toast, Inc.
Class A Common Stock
M - Exercise 7,640 16,952 82.04
2022-12-19 2022-12-15 4 TWLO TWILIO INC
Class A Common Stock
A - Award 1,565 5,798 36.97
2022-10-06 2022-10-05 4 GBT Global Blood Therapeutics, Inc.
Common Stock
D - Sale to Issuer -9,037 0 -100.00
2022-09-19 2022-09-15 4 TWLO TWILIO INC
Class A Common Stock
A - Award 1,008 4,233 31.26
2022-09-14 2022-09-12 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -47,705 0 -100.00 30.78 -1,468,422
2022-09-14 2022-09-12 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 47,705 47,705 12.62 602,037 602,037
2022-06-17 2022-06-15 4 TWLO TWILIO INC
Class A Common Stock
A - Award 736 3,225 29.57
2022-06-16 2022-06-14 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 3,600 9,037 66.21
2022-06-15 2022-06-13 4 AMWL American Well Corp
Class A Common Stock
A - Award 50,377 78,149 181.39
2022-04-22 2020-09-17 4 AMWL American Well Corp
Class A Common Stock
P - Purchase 8,000 8,000 18.00 144,000 144,000
2022-04-22 2020-09-17 4 AMWL American Well Corp
Class A Common Stock
P - Purchase 3,000 27,772 12.11 18.00 54,000 499,896
2022-03-17 2022-03-15 4 TWLO TWILIO INC
Class A Common Stock
A - Award 431 2,489 20.94
2022-02-24 2022-02-22 4 TOST Toast, Inc.
Restricted Stock Units
M - Exercise -7,645 15,285 -33.34
2022-02-24 2022-02-22 4 TOST Toast, Inc.
Class A Common Stock
M - Exercise 7,645 9,312 458.61
2021-12-17 2021-12-15 4 TWLO TWILIO INC
Class A Common Stock
A - Award 263 2,058 14.65
2021-11-04 2021-11-02 4 AMWL American Well Corp
Class A Common Stock
S - Sale X -5,166 24,772 -17.26 9.30 -48,020 230,263
2021-10-29 2021-10-27 4 TOST Toast, Inc.
Restricted Stock Units
J - Other 22,930 22,930
2021-10-29 2021-10-27 4 TOST Toast, Inc.
Restricted Stock Units
J - Other -22,930 0 -100.00
2021-09-27 2021-09-24 4 TOST Toast, Inc.
Restricted Stock Units
J - Other 22,930 22,930
2021-09-27 2021-09-24 4 TOST Toast, Inc.
Restricted Stock Units
J - Other -22,930 0 -100.00
2021-09-27 2021-09-24 4 TOST Toast, Inc.
Class A Common Stock
P - Purchase 1,667 1,667 40.00 66,680 66,680
2021-09-17 2021-09-15 4 TWLO TWILIO INC
Class A Common Stock
A - Award 210 1,795 13.25
2021-06-21 2021-06-17 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 3,600 3,600
2021-06-21 2021-06-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 5,600 5,600
2021-06-21 2021-06-17 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3,037 0 -100.00
2021-06-21 2021-06-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 3,037 5,437 126.54
2021-06-17 2021-06-16 4 TWLO TWILIO INC
Class A Common Stock
A - Award 318 1,585 25.10
2021-06-17 2021-06-15 4 AMWL American Well Corp
Class A Common Stock
A - Award 14,440 29,938 93.17
2021-02-03 2021-02-01 4 CERE Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
A - Award 90,390 90,390
2021-01-15 2021-01-13 4 TWLO TWILIO INC
Class A Common Stock
A - Award 1,267 1,267
2020-11-04 2020-11-02 4 AMWL American Well Corp
Class A Common Stock
A - Award 15,498 15,498
2020-06-29 2020-06-28 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2,400 2,400
2020-06-19 2020-06-17 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 3,037 3,037
2020-06-19 2020-06-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 5,247 5,247
2020-06-01 2020-05-28 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 2,400 2,400
2020-06-01 2020-05-28 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 625 625
2019-10-10 2019-10-08 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -5,357 0 -100.00
2019-10-10 2019-10-08 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale -5,357 0 -100.00 45.05 -241,333
2019-10-10 2019-10-08 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 5,357 5,357 3.40 18,214 18,214
2019-06-20 2019-06-18 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 4,800 4,800
2019-06-20 2019-06-18 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 7,500 7,500
2018-07-10 2018-07-06 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -4,018 5,357 -42.86
2018-07-10 2018-07-06 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -8,361 239 -97.22
2018-07-10 2018-07-06 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -15,000 0 -100.00
2018-07-10 2018-07-06 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -15,000 0 -100.00
2018-07-10 2018-07-06 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale -42,379 0 -100.00 43.40 -1,839,283
2018-07-10 2018-07-06 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 4,018 42,379 10.47 3.40 13,661 144,089
2018-07-10 2018-07-06 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 8,361 38,361 27.87 20.00 167,220 767,220
2018-07-10 2018-07-06 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 15,000 30,000 100.00 20.00 300,000 600,000
2018-07-10 2018-07-06 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 15,000 15,000 28.45 426,750 426,750
2018-06-22 2018-06-20 4 GBT Global Blood Therapeutics, Inc.
Stock Option (right to buy)
A - Award 15,000 15,000
2017-07-27 2017-07-25 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -15,000 0 -100.00
2017-07-27 2017-07-25 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -12,053 9,375 -56.25
2017-07-27 2017-07-25 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale -27,053 0 -100.00 29.69 -803,204
2017-07-27 2017-07-25 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 15,000 27,053 124.45 18.85 282,750 509,949
2017-07-27 2017-07-25 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 12,053 12,053 3.40 40,980 40,980
2017-06-22 2017-06-20 4 GBT Global Blood Therapeutics, Inc.
Stock Option (right to buy)
A - Award 15,000 15,000
2016-06-17 2016-06-16 4 GBT Global Blood Therapeutics, Inc.
Stock Option (right to buy)
A - Award 15,000 15,000
2016-01-07 2015-08-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
P - Purchase 2,500 2,500 20.00 50,000 50,000
2015-08-13 2015-08-11 4 GBT Global Blood Therapeutics, Inc.
Stock Option (right to buy)
A - Award 8,600 8,600
2015-08-13 2015-08-11 4 GBT Global Blood Therapeutics, Inc.
Stock Option (right to buy)
A - Award 15,000 15,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)